litlas
ログインアカウント作成

Salvatore Siena

1985–2026 年に発表

250
論文数
75,318
被引用数
116
h 指数
235
i10 指数

被引用数

Salvatore Siena の年別被引用数1988 年: 被引用 1 件1989 年: 被引用 8 件1990 年: 被引用 7 件1991 年: 被引用 13 件1992 年: 被引用 48 件1993 年: 被引用 48 件1994 年: 被引用 47 件1995 年: 被引用 52 件1996 年: 被引用 42 件1997 年: 被引用 40 件1998 年: 被引用 34 件1999 年: 被引用 38 件2000 年: 被引用 49 件2001 年: 被引用 26 件2002 年: 被引用 32 件2003 年: 被引用 40 件2004 年: 被引用 32 件2005 年: 被引用 108 件2006 年: 被引用 133 件2007 年: 被引用 187 件2008 年: 被引用 257 件2009 年: 被引用 405 件2010 年: 被引用 530 件2011 年: 被引用 495 件2012 年: 被引用 421 件2013 年: 被引用 491 件2014 年: 被引用 655 件2015 年: 被引用 751 件2016 年: 被引用 742 件2017 年: 被引用 853 件2018 年: 被引用 801 件2019 年: 被引用 2,678 件2020 年: 被引用 2,665 件2021 年: 被引用 2,737 件2022 年: 被引用 2,293 件2023 年: 被引用 1,850 件2024 年: 被引用 3,205 件2025 年: 被引用 1,745 件2026 年: 被引用 46 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,914 件、この内訳の 24.2%中国: 引用元論文 2,680 件、この内訳の 11%イタリア: 引用元論文 2,009 件、この内訳の 8.2%イギリス: 引用元論文 1,341 件、この内訳の 5.5%ドイツ: 引用元論文 1,254 件、この内訳の 5.1%フランス: 引用元論文 1,066 件、この内訳の 4.4%スペイン: 引用元論文 992 件、この内訳の 4.1%日本: 引用元論文 962 件、この内訳の 3.9%カナダ: 引用元論文 669 件、この内訳の 2.7%オランダ: 引用元論文 667 件、この内訳の 2.7%オーストラリア: 引用元論文 617 件、この内訳の 2.5%スイス: 引用元論文 521 件、この内訳の 2.1%
0%24.2%その他 23.6%

機関

分野

  • Medicine61.5%
  • Biochemistry, Genetics and Molecular Biology31.8%
  • Immunology and Microbiology2.3%
  • Engineering0.9%
  • Materials Science0.6%
  • Computer Science0.6%
  • その他2.3%

トピック

  • Cancer Genomics and Diagnostics8.8%
  • Colorectal Cancer Treatments and Studies6.8%
  • Lung Cancer Treatments and Mutations4.5%
  • Genetic factors in colorectal cancer3.9%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Cancer Cells and Metastasis2.7%
  • その他70.4%

共著者

全論文

検索で開く
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    著者: Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R. Bartlett, Hao Wang, Brandon Luber, Rhoda M. Alani, Emmanuel S. Antonarakis, Nilofer S. Azad, Alberto Bardelli, Henry Brem, John L. Cameron, Clarence Lee, Leslie A. Fecher, Gary L. Gallia, Peter Gibbs, Dung T. Le, Robert Giuntoli, Michael Goggins, Michael D. Hogarty, Matthias Holdhoff, Seung‐Mo Hong, Yuchen Jiao, Hartmut Juhl, Jaeyeon Kim, Giulia Siravegna, Daniel A. Laheru, Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 被引用: 5,110

  2. Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

    著者: Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin, Do‐Youn Oh, Susana Banerjee, Antonio González-Martı́n, Kyung Hae Jung, Iwona Ługowska, Luís Manso, Aránzazu Manzano, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Yan Ma, Soham D. Puvvada, Norah J. Shire, Jung‐Yun Lee - Journal of Clinical Oncology 2023 被引用: 931

  3. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

    著者: Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares, Salvatore Siena, Alice T. Shaw, Anna F. Farago, Collin M. Blakely, Takashi Seto, Byoung Chul Cho, Diégo Tosi, Benjamin Besse, Sant P. Chawla, Lyudmila Bazhenova, John C. Krauss, Young Kwang Chae, Minal Barve, Ignacio Garrido‐Laguna, Stephen V. Liu, Paul Conkling, Thomas John, Marwan Fakih, Darren Sigal, Herbert H. Loong, Gary L. Buchschacher, Pilar Garrido, Jorgé Nieva, Conor Steuer, Tobias R. Overbeck, Daniel W. Bowles, Elizabeth Fox, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, George D. Demetri - The Lancet Oncology 2019 被引用: 1,744

  4. Integrating liquid biopsies into the management of cancer

    著者: Giulia Siravegna, Silvia Marsoni, Salvatore Siena, Alberto Bardelli - Nature Reviews Clinical Oncology 2017 被引用: 1,918

  5. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    著者: Axel Grothey, Eric Van Cutsem, Alberto Sobrero, Salvatore Siena, Alfredo Falcone, Marc Ychou, Yves Humblet, Olivier Bouché, Laurent Mineur, Carlo Barone, Antoine Adenis, Josep Tabernero, Takayuki Yoshino, Heinz‐Josef Lenz, Richard M. Goldberg, Daniel J. Sargent, Frank Cihon, Lisa Cupit, Andrea Wagner, Dirk Laurent - The Lancet 2012 被引用: 2,897

  6. EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

    著者: Vito Amodio, Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato, Sabrina Arena, Monica Montone, Benedetta Mussolin, Yu Bian, Adele Whaley, Marika Pinnelli, Yonina R. Murciano‐Goroff, Efsevia Vakiani, Nicola Valeri, Wei‐Li Liao, Anuja Bhalkikar, Sheeno Thyparambil, HuiYong Zhao, Elisa de Stanchina, Silvia Marsoni, Salvatore Siena, Andrea Bertotti, Livio Trusolino, Bob T. Li, Neal Rosen, Federica Di Nicolantonio, Alberto Bardelli, Sandra Misale - Cancer Discovery 2020 被引用: 488

  7. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

    著者: John H. Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, Elena Élez, David L. Bajor, Chiara Cremolini, Federico Sanchez, Michael Stecher, Wentao Feng, Tanios Bekaii‐Saab, Eric Van Cutsem, Marc Peeters, Marc Van den Evnde, Thierry André, Christophe Borg, Matthieu Sarabi, François Ghiringhelli, Benoist Chibaudel, Salvatore Siena, Chiara Cremolini, Maria Giulia Zampino, Elena Élez, Susana R. Keranen, Ramón Salazar, Pilar Alfonso, John H. Strickler, Andrea Cercek, Kimmie Ng, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, David L. Bajor, Tanios Bekaii‐Saab, Olumide B. Gbolahan, Patrick M. Boland, Daniel Berg, Federico Sanchez, Timothy F. Goggins, Federico Sanchez, Howard A. Burris, Johanna C. Bendell, Darryl Outlaw, Isaac Tafur, Ardaman Shergill, Daniel V.T. Catenacci, Jun Gong, Ignacio Garrido‐Laguna, Gene Grant Finley, Benjamin A. Weinberg, Anthony F. Shields, Philip Philip, Anita Turk, Anthony Nguyen, Fadi Braiteh, Vijay Patel, William Harwin, Ian Anderson, Ajay Kundra, Christopher S. Chen, James M. Ford, Madappa N. Kundranda, Danny Nguyen, Suresh Ratnam, Donald Richards, Sujatha Nallapareddy, Sridhar Beeram, Scott McKenney, Spencer H. Shao, Scott McKenney, Spencer H. Shao - The Lancet Oncology 2023 被引用: 245

  8. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

    著者: Marcia S. Brose, Christopher M. Nutting, Barbara Jarząb, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardière, Furio Pacini, Ralf Paschke, Young Kee Shong, Steven I. Sherman, Johannes W. A. Smit, John Chung, Christian Kappeler, Carol Peña, István Molnár, Martin Schlumberger - The Lancet 2014 被引用: 1,638

  9. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study

    著者: Eric Van Cutsem, Maria Di Bartolomeo, Elizabeth Smyth, Ian Chau, Haeseong Park, Salvatore Siena, Sara Lonardi, Zev A. Wainberg, Jaffer A. Ajani, Joseph Chao, Yelena Y. Janjigian, Amy Qin, Jasmeet Singh, Ferdous M. Barlaskar, Yoshinori Kawaguchi, Geoffrey Y. Ku - The Lancet Oncology 2023 被引用: 242

  10. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

    著者: Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi, Francesca Bergamo, Vittorina Zagonel, Francesco Leone, Ilaria Depetris, Erika Martinelli, Teresa Troiani, Fortunato Ciardiello, Patrizia Racca, Andrea Bertotti, Giulia Siravegna, Valter Torri, Alessio Amatu, Silvia Ghezzi, Giovanna Marrapese, Laura Palmeri, Emanuele Valtorta, Andrea Cassingena, Calogero Lauricella, Angelo Vanzulli, Daniele Regge, Silvio Veronese, Paolo M. Comoglio, Alberto Bardelli, Silvia Marsoni, Salvatore Siena - The Lancet Oncology 2016 被引用: 1,009

  11. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

    著者: Sandra Misale, Rona Yaeger, Sebastijan Hobor, Elisa Scala, Manickam Janakiraman, David Liska, Emanuele Valtorta, Roberta Schiavo, Michela Buscarino, Giulia Siravegna, Katia Bencardino, Andrea Cercek, Chin‐Tung Chen, Silvio Veronese, Carlo Zanon, Andrea Sartore‐Bianchi, Marcello Gambacorta, Margherita Gallicchio, Efsevia Vakiani, Valentina Boscaro, Enzo Médico, Martin R. Weiser, Salvatore Siena, Federica Di Nicolantonio, David B. Solit, Alberto Bardelli - Nature 2012 被引用: 1,914

  12. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

    著者: Salvatore Siena, Maria Di Bartolomeo, Kanwal Raghav, Toshiki Masuishi, Fotios Loupakis, Hisato Kawakami, Kensei Yamaguchi, Tomohiro Nishina, Marwan Fakih, Élena Elez, Javier Rodríguez, Fortunato Ciardiello, Yoshito Komatsu, Taito Esaki, Ki Y. Chung, Zev A. Wainberg, Andrea Sartore‐Bianchi, Kapil Saxena, Eriko Yamamoto, Emarjola Bako, Yasuyuki Okuda, Javad Shahidi, Axel Grothey, Takayuki Yoshino - The Lancet Oncology 2021 被引用: 413

  13. Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

    著者: Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi, Benedetta Mussolin, Francesco Rua, Giovanni Crisafulli, Alice Bartolini, Elisabetta Fenocchio, Alessio Amatu, Paolo Manca, Francesca Bergamo, Federica Tosi, Gianluca Mauri, Margherita Ambrosini, Francesca Daniel, Valter Torri, Angelo Vanzulli, Daniele Regge, Giovanni Cappello, Caterina Marchiò, Enrico Berrino, Anna Sapino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli - Nature Medicine 2022 被引用: 261

  14. Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer

    著者: Jean‐Yves Douillard, Kelly S. Oliner, Salvatore Siena, Josep Tabernero, Ronald L. Burkes, Mario Barugel, Yves Humblet, G. Bodoky, David Cunningham, Jacek Jassem, Fernando Rivera, Ilona Kocáková, Paul Ruff, Maria Błasińska-Morawiec, Martin Šmakal, Jean Luc Canon, M. Rother, Richard T. Williams, Alan Rong, Jeffrey S. Wiezorek, Roger Sidhu, Scott D. Patterson - New England Journal of Medicine 2013 被引用: 2,247

  15. Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

    著者: Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, Toshiki Masuishi, Fotios Loupakis, Hisato Kawakami, Kensei Yamaguchi, Tomohiro Nishina, Zev A. Wainberg, Elena Élez, J. Rodríguez, Marwan Fakih, Fortunato Ciardiello, Kapil Saxena, Kojiro Kobayashi, Emarjola Bako, Yasuyuki Okuda, Gerold Meinhardt, Axel Grothey, Salvatore Siena, DESTINY-CRC01 investigators, Maria Di Bartolomeo - Nature Communications 2023 被引用: 161

  16. Early‐onset colorectal cancer in young individuals

    著者: Gianluca Mauri, Andrea Sartore‐Bianchi, Antonio Russo, Silvia Marsoni, Alberto Bardelli, Salvatore Siena - Molecular Oncology 2018 被引用: 667

  17. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

    著者: David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, D. Bets, M. Mueser, A. Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem - New England Journal of Medicine 2004 被引用: 5,049

  18. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

    著者: Cathy Eng, Tae Won Kim, Johanna C. Bendell, Guillem Argilés, Niall C. Tebbutt, Maria Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark Kozloff, Neil H. Segal, Alberto Sobrero, Yibing Yan, Ilsung Chang, Anne Uyei, Louise Roberts, Fortunato Ciardiello, JB Ahn, Jamil Asselah, Suprith Badarinath, Shobhit Baijal, S. Begbie, Sneha Berry, J. R. Canon, RG Carbone, Andrés Cervantes, YJ Cha, Karen Chang, Arvind Chaudhry, Ewa Chmielowska, Seung‐Hun Cho, Derek K. Chu, Félix Couture, Jennifer L. Cultrera, David Cunningham, Eric Van Cutsem, P-J. Cuyle, Janine M. Davies, Scot Dowden, Mikhail Dvorkin, Vinod Ganju, RV Garcia, Rachel Kerr, Tae‐Yop Kim, Kevin G. King, Jeremy Kortmansky, Mark Kozloff, Ko Lam, J Lee, AS Lee, Bernard Lespérance, Gabriele Luppi, Boyu Ma, Evaristo Maiello, Romeo A. Mandanas, J. L. Marshall, Gavin Marx, Saifee Mullamitha, Marina Nechaeva, Jo Park, Nick Pavlakis, CG Ponce, Piotr Potemski, Sherif Raouf, James A. Reeves, Neil H. Segal, Salvatore Siena, Alexey Smolin, JO Streb, A. H. Strickland, Ewa Szutowicz-Zielińska, Josep Tabernero, Benjamin Tan, JS Valera, Marc Van den Eynde, Philippe Vergauwe, Michael M. Vickers, Mark Womack, Marta Wróblewska, Ruth T. Young - The Lancet Oncology 2019 被引用: 562

  19. Adaptive mutability of colorectal cancers in response to targeted therapies

    著者: Mariangela Russo, Giovanni Crisafulli, Alberto Sogari, Nicole M. Reilly, Sabrina Arena, Simona Lamba, Alice Bartolini, Vito Amodio, Alessandro Magrì, Luca Novara, Ivana Sarotto, Zachary D. Nagel, Cortt G. Piett, Alessio Amatu, Andrea Sartore‐Bianchi, Salvatore Siena, Andrea Bertotti, Livio Trusolino, Mattia Corigliano, Marco Gherardi, Marco Cosentino Lagomarsino, Federica Di Nicolantonio, Alberto Bardelli - Science 2019 被引用: 446

  20. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    著者: Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T. Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent‐Puig, Frédérique Penault–Llorca, Philippe Rougier, Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Federico Cappuzzo, Milo Frattini, Francesca Molinari, Piercarlo Saletti, Sara De Dosso, Miriam Martini, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi, Josep Tabernero, Teresa Macarulla, Frédéric FIORE, Alice Gangloff, Fortunato Ciardiello, Per Pfeiffer, Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar - The Lancet Oncology 2010 被引用: 2,143

  21. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

    著者: Giovanni Germano, Simona Lamba, Giuseppe Rospo, Ludovic Barault, Alessandro Magrì, Federica Maione, Mariangela Russo, Giovanni Crisafulli, Alice Bartolini, Giulia Lerda, Giulia Siravegna, Benedetta Mussolin, Roberta Frapolli, Monica Montone, Federica Morano, Filippo de Braud, Nabil Amirouchene-Angelozzi, Silvia Marsoni, Maurizio D’Incalci, Armando Orlandi, Enrico Giraudo, Andrea Sartore‐Bianchi, Salvatore Siena, Filippo Pietrantonio, Federica Di Nicolantonio, Alberto Bardelli - Nature 2017 被引用: 644

  22. Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

    著者: Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz‐Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, ­Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schüler, Yun Fan, Giuseppe Curigliano - Nature Medicine 2022 被引用: 239

  23. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

    著者: Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Giorgio Corti, Andrea Cassingena, Giovanni Crisafulli, Agostino Ponzetti, Chiara Cremolini, Alessio Amatu, Calogero Lauricella, Simona Lamba, Sebastijan Hobor, Antonio Avallone, Emanuele Valtorta, Giuseppe Rospo, Enzo Médico, Valentina Motta, Carlotta Antoniotti, Fabiana Tatangelo, Beatríz Bellosillo, Silvio Veronese, Alfredo Budillon, Clara Montagut, Patrizia Racca, Silvia Marsoni, Alfredo Falcone, Ryan B. Corcoran, Federica Di Nicolantonio, Fotios Loupakis, Salvatore Siena, Andrea Sartore‐Bianchi, Alberto Bardelli - Nature Medicine 2015 被引用: 1,096

  24. Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer

    著者: Ryan B. Corcoran, Thierry André, Chloé E. Atreya, Jan H.M. Schellens, Takayuki Yoshino, Johanna C. Bendell, Antoine Hollebecque, Autumn J. McRee, Salvatore Siena, Gary Middleton, Kei Muro, Michael S. Gordon, Josep Tabernero, Rona Yaeger, Peter J. O’Dwyer, Y. Humblet, Filip De Vos, A. Scott Jung, Jan C. Brase, Savina Jaeger, Severine Bettinger, Bijoyesh Mookerjee, Fatima Rangwala, Eric Van Cutsem - Cancer Discovery 2018 被引用: 583